Reassessing the Risk of Severe Parvovirus B19 Infection in the Immunocompetent Population: A Call for Vigilance in the Wake of Resurgence
Abstract
:1. Introduction
2. B19V, an Old Virus: What is New?
3. A New Epidemiology for Parvovirus B19
4. Clinical Implication and Perspectives
5. Current Diagnostic Challenges
6. A Call for Proactive Clinical Management
Author Contributions
Funding
Conflicts of Interest
References
- Qiu, J.; Soderlund-Venermo, M.; Young, N.S. Human Parvoviruses. Clin. Microbiol. Rev. 2017, 30, 43–113. [Google Scholar] [CrossRef] [PubMed]
- Manaresi, E.; Gallinella, G. Advances in the Development of Antiviral Strategies against Parvovirus B19. Viruses 2019, 11, 659. [Google Scholar] [CrossRef] [PubMed]
- Ganaie, S.S.; Qiu, J. Recent Advances in Replication and Infection of Human Parvovirus B19. Front. Cell. Infect. Microbiol. 2018, 8, 166. [Google Scholar] [CrossRef] [PubMed]
- Boissiere, J.; Watkins, V.; Kuller, J.A.; Dotters-Katz, S.K.M. Parvovirus B19 in Pregnancy. Obstet. Gynecol. Surv. 2024, 79, 281–289. [Google Scholar] [CrossRef] [PubMed]
- Dittmer, F.P.; Guimarães, C.d.M.; Peixoto, A.B.; Pontes, K.F.M.; Bonasoni, M.P.; Tonni, G.; Júnior, E.A. Parvovirus B19 Infection and Pregnancy: Review of the Current Knowledge. J. Pers. Med. 2024, 14, 139. [Google Scholar] [CrossRef] [PubMed]
- Attwood, L.O.; Holmes, N.E.; Hui, L. Identification and management of congenital parvovirus B19 infection. Prenat. Diagn. 2020, 40, 1722–1731. [Google Scholar] [CrossRef] [PubMed]
- Obeid, K.M. Infections with DNA Viruses, Adenovirus, Polyomaviruses, and Parvovirus B19 in Hematopoietic Stem Cell Transplant Recipients and Patients with Hematologic Malignancies. Infect. Dis. Clin. North Am. 2019, 33, 501–521. [Google Scholar] [CrossRef]
- Nordholm, A.C.; Møller, F.T.; Ravn, S.F.; Sørensen, L.F.; Moltke-Prehn, A.; Mollerup, J.E.; Funk, T.; Sperling, L.; Jeyaratnam, U.; Franck, K.T.; et al. Epidemic of parvovirus B19 and disease severity in pregnant people, Denmark, January to March 2024. Eurosurveillance 2024, 29, 2400299. [Google Scholar] [CrossRef]
- D’humières, C.; Fouillet, A.; Verdurme, L.; Lakoussan, S.-B.; Gallien, Y.; Coignard, C.; Hervo, M.; Ebel, A.; Soares, A.; Visseaux, B.; et al. An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024. Eurosurveillance 2024, 29, 2400339. [Google Scholar] [CrossRef]
- European Centre for Disease Prevention and Control. Risks Posed by Reported Increased Circulation of Human Parvovirus B19 in the EU/EEA. 5 June 2024. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/Risks%20posed%20by%20reported%20increased%20circulation%20of%20human%20parvovirus%20B19%20FINAL.pdf (accessed on 6 July 2024).
- Simmonds, P.; Aiewsakun, P.; Katzourakis, A. Prisoners of war—Host adaptation and its constraints on virus evolution. Nat. Rev. Microbiol. 2019, 17, 321–328. [Google Scholar] [CrossRef]
- De-Dios, T.; Scheib, C.L.; Houldcroft, C.J. An Adagio for Viruses, Played Out on Ancient DNA. Genome Biol. Evol. 2023, 15, evad047. [Google Scholar] [CrossRef] [PubMed]
- Slavov, S.N.; Kashima, S.; Pinto, A.C.S.; Covas, D.T. Human parvovirus B19: General considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions. FEMS Immunol. Med. Microbiol. 2011, 62, 247–262. [Google Scholar] [CrossRef] [PubMed]
- Heegaard, E.D.; Brown, K.E. Human parvovirus B19. Clin. Microbiol. Rev. 2002, 15, 485–505. [Google Scholar] [CrossRef]
- Luo, Y.; Qiu, J. Human Parvovirus B19: A Mechanistic Overview of Infection and DNA Replication. Future Virol. 2015, 10, 155–167. [Google Scholar] [CrossRef] [PubMed]
- Guan, W.; Wong, S.; Zhi, N.; Qiu, J. The genome of human parvovirus B19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus. J. Virol. 2009, 83, 9541–9553. [Google Scholar] [CrossRef] [PubMed]
- Slavov, S.N.; Rodrigues, E.S.; Sauvage, V.; Caro, V.; Diefenbach, C.F.; Zimmermann, A.M.; Covas, D.T.; Laperche, S.; Kashima, S. Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil. J. Med. Virol. 2019, 91, 1224–1231. [Google Scholar] [CrossRef]
- Russcher, A.; van Boven, M.; Benincà, E.; Verweij, E.J.T.; Backer, M.W.A.M.-D.; Zaaijer, H.L.; Vossen, A.C.T.M.; Kroes, A.C.M. Changing epidemiology of parvovirus B19 in the Netherlands since 1990, including its re-emergence after the COVID-19 pandemic. Sci. Rep. 2024, 14, 9630. [Google Scholar] [CrossRef] [PubMed]
- Gokhale, D.V.; Brett, T.S.; He, B.; King, A.A.; Rohani, P. Disentangling the causes of mumps reemergence in the United States. Proc. Natl. Acad. Sci. USA 2023, 120, e2207595120. [Google Scholar] [CrossRef] [PubMed]
- Anderson, M.J.; Jones, S.E.; Minson, A.C. Diagnosis of human parvovirus B19 infections by dot-blot hybridization using cloned viral DNA. J. Virol. Methods 1986, 13, 301–308. [Google Scholar]
- Giovanetti, M.; Cella, E.; Benedetti, F.; Magalis, B.R.; Fonseca, V.; Fabris, S.; Campisi, G.; Ciccozzi, A.; Angeletti, S.; Borsetti, A.; et al. SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy. Commun. Biol. 2021, 4, 489. [Google Scholar] [CrossRef]
- Cutrera, R.; degli Atti, M.L.C.; Dotta, A.; D’amore, C.; Ravà, L.; Perno, C.F.; Villani, A. Epidemiology of respiratory syncytial virus in a large pediatric hospital in Central Italy and development of a forecasting model to predict the seasonal peak. Ital. J. Pediatr. 2024, 50, 65. [Google Scholar] [CrossRef] [PubMed]
- Guillet, M.; Bas, A.; Lacoste, M.; Ricard, C.; Visse, C.; Barlet, V.; Malard, L.; Le Cam, S.; Morel, P.; de Lamballerie, X.; et al. New atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24. Eurosurveillance 2024, 29, 2400253. [Google Scholar] [CrossRef]
- Jia, J.; Ma, Y.; Zhao, X.; Huangfu, C.; Zhong, Y.; Fang, C.; Fan, R.; Lv, M.; Zhang, J. Existence of various human parvovirus B19 genotypes in Chinese plasma pools: Genotype 1, genotype 3, putative intergenotypic recombinant variants and new genotypes. Virol. J. 2016, 13, 155. [Google Scholar] [CrossRef] [PubMed]
- Hubschen, J.M.; Mihneva, Z.; Mentis, A.F.; Schneider, F.; Aboudy, Y.; Grossman, Z.; Rudich, H.; Kasymbekova, K.; Sarv, I.; Nedeljkovic, J.; et al. Phylogenetic analysis of human parvovirus B19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b. J. Clin. Microbiol. 2009, 47, 3735–3738. [Google Scholar] [CrossRef] [PubMed]
- Staten Serum Institute. Parvovirus B19 and Pregnancy (2024). Available online: https://en.ssi.dk/news/epi-news/2024/no-13---2024 (accessed on 31 July 2024).
- Health Protection Surveillance Centre. Parvovirus B19 Epidemiological Data. 2024. Available online: https://www.hpsc.ie/a-z/other/parvovirus/epidemiologicaldata/ (accessed on 31 July 2024).
- Hooiveld, M.; Baliatsas, C.; van Summeren, J.; Stelma, F.F. Nivel-cijfers Ziekten per week in Nederland—Actueel: Wat heerst er? Available online: https://www.nivel.nl/nl/zorg-en-ziekte-in-cijfers/actuele-cijfers-ziekten-per-week (accessed on 31 July 2024).
- UK Health Security Agency (UKHSA). Increasing Levels of Parvovirus B19 Activity in England (2024). Available online: https://www.gov.uk/government/publications/health-protection-report-volume-18-2024/hpr-volume-18-issue-5-news-16-may-2024 (accessed on 31 July 2024).
- Centro Nacional de Epidemiología. ISCIII. Boletín Semanal en Red. 2024 N27. Available online: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Boletines/Documents/Boletin_Epidemiologico_en_red/Boletines%20en%20Red%202024/IS_N%C2%BA27-20240702_WEB.pdf (accessed on 31 July 2024).
- Raquena, E. Malaga Records Huge Increase of Slapped Cheek Syndrome Cases. Surinenglish 2024. Available online: https://www.surinenglish.com/malaga/malaga-recorded-2267-more-cases-the-slap-20240628074313-nt.html (accessed on 31 July 2024).
- European Centre for Disease Prevention and Control (ECDC). Network for the Microbial Safety of Substances of Human Origin (SoHO-Net). Stockholm: ECDC. 2024. Available online: https://www.ecdc.europa.eu/en/aboutecdc/what-we-do/partners-and-networks/disease-and-laboratory-networks/network-microbial (accessed on 1 August 2024).
- Santé publique France. Epidémie d’infections à Parvovirus B19 en France. Point au 22 avril 2024. Saint Maurice: SpF. 2024. Available online: https://www.santepubliquefrance.fr/docs/epidemie-d-infections-aparvovirus-b19-en-france.-point-au-22-avril-2024 (accessed on 1 August 2024).
- European Centre for Disease Prevention and Control (ECDC). Communicable Disease Threats Report—31 March–6 April 2024, Week 14. Stockholm: ECDC. 2024. Available online: https://www.ecdc.europa.eu/en/publications-data/communicable-disease-threats-report-31-march-6-april2024-week-14 (accessed on 1 August 2024).
- Patalon, T.; Saciuk, Y.; Trotzky, D.; Pachys, G.; Ben-Tov, A.; Segal, Y.; Gazit, S. An Outbreak of Parvovirus B19 in Israel. Viruses 2023, 15, 2261. [Google Scholar] [CrossRef]
- Burrell, C.J.; Howard, C.R.; Murphy, F.A. Emerging Virus Diseases. Fenner White’s Med. Virol. 2017, 217–225. [Google Scholar] [CrossRef]
- Kishore, J.; Kishore, D. Clinical impact & pathogenic mechanisms of human parvovirus B19: A multiorgan disease inflictor incognito. Indian J. Med. Res. 2018, 148, 373–384. [Google Scholar] [CrossRef]
- Monteiro, V.S.; Baía-Da-Silva, D.C.; Silva, V.A.; João, G.A.P.; Marinho, E.P.M.; Cubas-Vega, N.C.; Val, F.F.A.; Perez-Gomez, A.S.; Monte, R.L.; Mota, A.; et al. Neurological Manifestations Associated with Parvovirus B19 Infection in Immunocompetent Children: Case Series and Systematic Review. J. Trop. Pediatr. 2021, 67, fmab078. [Google Scholar] [CrossRef]
- Mor, O.; Wax, M.; Arami, S.-S.; Yitzhaki, M.; Kriger, O.; Erster, O.; Zuckerman, N.S. Parvovirus B19 Outbreak in Israel: Retrospective Molecular Analysis from 2010 to 2023. Viruses 2024, 16, 480. [Google Scholar] [CrossRef]
- Ceccarelli, G.; Russo, A.; Fabris, S.; Ciccozzi, M.; D’Ettorre, G. SARS-CoV-2 pandemic, influenza, and influenza-like illness epidemics: Allies or enemies? J. Med. Virol. 2023, 95, e28148. [Google Scholar] [CrossRef]
- Spagnolello, O.; Pierangeli, A.; Cedrone, M.C.; Di Biagio, V.; Gentile, M.; Leonardi, A.; Valeriano, C.; Innocenti, G.P.; Santinelli, L.; Borrazzo, C.; et al. Viral community acquired pneumonia at the emergency department: Report from the pre COVID-19 age. J. Med. Virol. 2021, 93, 4399–4404. [Google Scholar] [CrossRef]
- Ceccarelli, G.; Pinacchio, C.; Ciccozzi, M.; D’Ettorre, G. Preventing influenza and influenza like illness during Covid-19 pandemic: A call for action. Early Hum. Dev. 2022, 169, 105156. [Google Scholar] [CrossRef]
- Ceccarelli, G.; Innocenti, G.P.; Mastroianni, C.M.; Ciccozzi, M.; D’ettorre, G. Is previous influenza-like illness a potential Trojan horse for COVID-19? Crit. Care 2020, 24, 503. [Google Scholar] [CrossRef] [PubMed]
- Hong, C.; Li, B.; Wang, X.; Gao, Y.; Yuan, W.; He, Q.; Lan, X.; Lai, Q.; Luo, W.; Qi, T.; et al. Parvovirus B19 infection associated with adverse outcomes in decompensated cirrhosis patients. Poster presentations: Cirrhosis and its complications and critical illness. J. Hepatol. 2023, 78 (Suppl. 1), S202–S203. [Google Scholar] [CrossRef]
- Luo, J.; Zhang, J.; Lai, W.; Wang, S.; Zhou, L.; Shi, Y.; Ba, J.; Hu, J.; Wang, Y.; Li, L.; et al. Disseminated Human Parvovirus B19 Infection Induced Multiple Organ Dysfunction Syndrome in an Adult Patient With Alcoholic Hepatitis Complicated by Hemolytic Anemia: A Case Report and Literature Review. Front. Immunol. 2021, 12, 742990. [Google Scholar] [CrossRef] [PubMed]
- Mendes-De-Almeida, D.P.; Bokel, J.P.B.; Alves, A.D.R.; Vizzoni, A.G.; Tavares, I.C.F.; Silva, M.S.T.; Netto, J.d.S.B.; Grinsztejn, B.G.J.; Leon, L.A.A. Clinical Presentation of Parvovirus B19 Infection in Adults Living with HIV/AIDS: A Case Series. Viruses 2023, 15, 1124. [Google Scholar] [CrossRef] [PubMed]
- Xiang, C.; Wu, X.; Wei, Y.; Li, T.; Tang, X.; Wang, Y.; Zhang, X.; Huang, X.; Wang, Y. First report on severe septic shock associated with human Parvovirus B19 infection after cardiac surgery. Front. Cell. Infect. Microbiol. 2023, 13, 1064760. [Google Scholar] [CrossRef] [PubMed]
- Matsui, D.; Aomura, D.; Nimura, T.; Yamaka, K.; Hashimoto, K.; Kamijo, Y. A Case of Severe Parvovirus B19 Infection with Glomerulonephritis Requiring Artificial Ventilation. J. Am. Soc. Nephrol. 2023, 34, 1125–1126. [Google Scholar] [CrossRef]
- Khan, U.; Ahmad, R.U.; Ullah, Z.; Fida, T.; Shehryar, M. Parvovirus b19-Induced Acute Hepatitis With Hepatosplenomegaly and Polyarthropathy. Cureus 2022, 14, e21494. [Google Scholar] [CrossRef]
- Nandan, D.; Singh, D.P.; Agarwal, S.; Singh, R.; Gupta, A. Therapeutic Plasma Exchange in Parvovirus B19-induced Acute Hepatic Failure. Indian J. Crit. Care Med. 2020, 24, 361–362. [Google Scholar] [CrossRef]
- Callon, D.; Joanne, P.; Andreoletti, L.; Agbulut, O.; Chevalier, P.; Fornès, P. Viral myocarditis in combination with genetic cardiomyopathy as a cause of sudden death. An autopsy series. BMC Cardiovasc. Disord. 2024, 24, 282. [Google Scholar] [CrossRef] [PubMed]
- Ackermann, M.; Wagner, W.L.; Rellecke, P.; Akhyari, P.; Boeken, U.; Reinecke, P. Parvovirus B19-induced angiogenesis in fulminant myocarditis. Eur. Heart J. 2020, 41, 1309. [Google Scholar] [CrossRef] [PubMed]
- Pesce, R.; Taffarello, P.; Rizzo, S.; Basso, C.; Cacciavillani, L.; Del Monte, A.; Babuin, L.; Gerosa, G.; Bottio, T. Fulminant myocarditis parvovirus B19 related in a young woman. J. Artif. Organs 2021, 24, 498–502. [Google Scholar] [CrossRef] [PubMed]
- Saturno, M.C.; Manni, P.; Accorinti, M. Bilateral Conjunctivitis, Keratitis, and Anterior Uveitis in a Patient Co-infected with Parvovirus B19 and SARS-CoV-2. Case Rep. Ophthalmol. 2022, 13, 979–983. [Google Scholar] [CrossRef] [PubMed]
- Ghimire, A.; Platnich, J.; Chauhan, U. Warm Autoimmune Hemolytic Anemia and Pure Red Cell Aplasia during a Severe COVID-19 B.1.1.7 Infection. Infect. Dis. Rep. 2022, 14, 413–419. [Google Scholar] [CrossRef] [PubMed]
- Guo, J.; Wang, Y.; Zhang, M.; Zheng, H.; Zang, Q.; Huang, P.; Wen, L.; Song, D.; Yang, F.; Dong, R.; et al. Human parvovirus B19 infection in hospitalized patients suspected of infection with pathogenic microorganism. Front. Cell. Infect. Microbiol. 2022, 12, 1083839. [Google Scholar] [CrossRef]
- Giovanetti, M.; Branda, F.; Scarpa, F.; Ciccozzi, M.; Ceccarelli, G. Letter to the editor: Severe parvovirus B19 infections in the immunocompetent population. Eurosurveillance 2024, 29, 2400438. [Google Scholar] [CrossRef]
- Zakrzewska, K.; Arvia, R.; Bua, G.; Margheri, F.; Gallinella, G. Parvovirus B19: Insights and implication for pathogenesis, prevention and therapy. Asp. Mol. Med. 2023, 1, 100007. [Google Scholar] [CrossRef]
- Landry, M.L. Parvovirus B19. Microbiol. Spectr. 2016, 4, 297–310. [Google Scholar] [CrossRef]
- Brown, K.E.; Simmonds, P. Parvoviruses and blood transfusion. Transfusion 2007, 47, 1745–1750. [Google Scholar] [CrossRef]
- Babawale, P.I.; Guerrero-Plata, A. Respiratory Viral Coinfections: Insights into Epidemiology, Immune Response, Pathology, and Clinical Outcomes. Pathogens 2024, 13, 316. [Google Scholar] [CrossRef] [PubMed]
- Lalbiaktluangi, C.; Yadav, M.K.; Singh, P.K.; Singh, A.; Iyer, M.; Vellingiri, B.; Zomuansangi, R.; Zothanpuia; Ram, H. A cooperativity between virus and bacteria during respiratory infections. Front. Microbiol. 2023, 14, 1279159. [Google Scholar] [CrossRef]
- Clark, J.J.; Penrice-Randal, R.; Sharma, P.; Dong, X.; Pennington, S.H.; Marriott, A.E.; Colombo, S.; Davidson, A.; Williamson, M.K.; Matthews, D.A.; et al. Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19. Viruses 2024, 16, 863. [Google Scholar] [CrossRef] [PubMed]
- Field-Cortazares, J.; Coria-Lorenzo, J.J.; Domingo-Martínez, D.; Moctezuma-Paz, L.E. Coinfections and comorbidities observed in COVID-19 during the influenza season in the pediatric patient. Cir Cir. 2024, 92, 298–306. [Google Scholar] [CrossRef] [PubMed]
- Callon, D.; Berri, F.; Lebreil, A.-L.; Fornès, P.; Andreoletti, L. Coinfection of Parvovirus B19 with Influenza A/H1N1 Causes Fulminant Myocarditis and Pneumonia. An Autopsy Case Report. Pathogens 2021, 10, 958. [Google Scholar] [CrossRef] [PubMed]
- Grolhier, C.; Pronier, C.; Belem, A.; Dina, J.; Vabret, A.; Grau, J.-H.A.; Tattevin, P.; Thibault, V. When a viral eruption hides another one: Intrafamilial outbreak of parvovirus B19 and measles virus co-infections: Case report. BMC Infect. Dis. 2020, 20, 496. [Google Scholar] [CrossRef] [PubMed]
- Toan, N.L.; Sy, B.T.; Song, L.H.; Luong, H.V.; Binh, N.T.; Binh, V.Q.; Kandolf, R.; Velavan, T.P.; Kremsner, P.G.; Bock, C.-T. Co-infection of human parvovirus B19 with Plasmodium falciparum contributes to malaria disease severity in Gabonese patients. BMC Infect. Dis. 2013, 13, 375. [Google Scholar] [CrossRef]
- Duedu, K.O.; Sagoe, K.W.C.; Ayeh-Kumi, P.F.; Affrim, R.B.; Adiku, T. The effects of co-infection with human parvovirus B19 and Plasmodium falciparum on type and degree of anaemia in Ghanaian children. Asian Pac. J. Trop. Biomed. 2013, 3, 129–139. [Google Scholar] [CrossRef]
- Cefalo, M.G.; Arlotta, A.; Maurizi, P.; Russo, I.; Sani, I.; Battista, A.; Mastrangelo, S.; Ruggiero, A.; Riccardi, R. Human parvovirus B 19 and Epstein-Barr virus co-infection in a child with hereditary spherocytosis. Eur. Rev. Med. Pharmacol. Sci. 2012, 16, 265–269. [Google Scholar]
- Ingrassia, F.; Gadaleta, A.; Maggi, P.; Pastore, G. Plasmodium falciparum malaria and Parvovirus B19; A case of acute co-infection. BMC Infect. Dis. 2010, 10, 87. [Google Scholar] [CrossRef]
- Dwivedi, M.; Manocha, H.; Tiwari, S.; Tripathi, G.; Dhole, T.N. Coinfection of parvovirus b19 with other hepatitis viruses leading to fulminant hepatitis of unfavorable outcome in children. Pediatr. Infect. Dis. J. 2009, 28, 649–650. [Google Scholar] [CrossRef] [PubMed]
- Kishore, J.; Sen, M. Parvovirus B19-induced Thrombocytopenia and Anemia in a Child with Fatal Fulminant Hepatic Failure Coinfected with Hepatitis A and E Viruses. J. Trop. Pediatr. 2009, 55, 335–337. [Google Scholar] [CrossRef] [PubMed]
- Toan, N.L.; Song, L.H.; Kremsner, P.G.; Duy, D.N.; Binh, V.Q.; Duechting, A.; Kaiser, H.; Torresi, J.; Kandolf, R.; Bock, C.-T. Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection. J. Hepatol. 2006, 45, 361–369. [Google Scholar] [CrossRef] [PubMed]
- Sim, J.Y.; Chang, L.-Y.; Chen, J.-M.; Lee, P.-I.; Huang, L.-M.; Lu, C.-Y. Human parvovirus B19 infection in patients with or without underlying diseases. J. Microbiol. Immunol. Infect. 2019, 52, 534–541. [Google Scholar] [CrossRef] [PubMed]
- Lindblom, A.; Isa, A.; Norbeck, O.; Wolf, S.; Johansson, B.; Broliden, K.; Tolfvenstam, T. Slow Clearance of Human Parvovirus B19 Viremia following Acute Infection. Clin. Infect. Dis. 2005, 41, 1201–1203. [Google Scholar] [CrossRef]
- Gallinella, G. The clinical use of parvovirus B19 assays: Recent advances. Expert Rev. Mol. Diagn. 2018, 18, 821–832. [Google Scholar] [CrossRef]
- de Haan, T.R. Clinical and Virological Aspects of Human Parvovirus B19 Infection during Gestation. 13 November 2007. Available online: https://hdl.handle.net/1887/12426 (accessed on 1 August 2024).
- Corcoran, C.; Hardie, D.; Yeats, J.; Smuts, H. Genetic variants of human parvovirus B19 in South Africa: Cocirculation of three genotypes and identification of a novel subtype of genotype 1. J. Clin. Microbiol. 2010, 48, 137–142. [Google Scholar] [CrossRef]
- Jain, A.; Kant, R. Genotypes of erythrovirus B19, their geographical distribution & circulation in cases with various clinical manifestations. Indian J. Med. Res. 2018, 147, 239–247. [Google Scholar] [CrossRef]
- Besedovsky, L.; Lange, T.; Haack, M. The Sleep-Immune Crosstalk in Health and Disease. Physiol. Rev. 2019, 99, 1325–1380. [Google Scholar] [CrossRef]
- Shao, T.; Verma, H.K.; Pande, B.; Costanzo, V.; Ye, W.; Cai, Y.; Bhaskar, L.V.K.S. Physical Activity and Nutritional Influence on Immune Function: An Important Strategy to Improve Immunity and Health Status. Front. Physiol. 2021, 12, 751374. [Google Scholar] [CrossRef]
- Weyh, C.; Krüger, K.; Strasser, B. Physical Activity and Diet Shape the Immune System during Aging. Nutrients 2020, 12, 622. [Google Scholar] [CrossRef]
- Musiani, M.; Manaresi, E.; Gallinella, G.; Cricca, M.; Zerbini, M. Recurrent Erythema in patients with long-term parvovirus B19 infection. Clin. Infect. Dis. 2005, 40, e117–e119. [Google Scholar] [CrossRef] [PubMed]
Traditional Risk Factors | Immuno Competent Individuals | ||
---|---|---|---|
Immuno Compromised Individuals | Pregnancy | ||
Clinical presentation | Chronic Anemia Aplastic Crisis Other Complications: Myocarditis, encephalitis, and hepatitis | Fetal Hydrops Miscarriage Stillbirth | Erythema Infectiosum
Arthralgia and Arthritis Less common: fatigue, sore throat, diarrhea, and conjunctivitis. |
Diagnostic Method | Description | Key Findings | Clinical Implication |
---|---|---|---|
Cytopathology | Identification of giant pronormoblasts in BM or peripheral blood. | Suggestive of B19V infection, but not definitive. Often absent in HIV or chronic infections. | Should be used in conjunction with other diagnostic methods. |
Electron Microscopy (EM) | Detection of B19V in serum. | Limited sensitivity and availability; not commonly used. | Supplementary method; not routinely used in diagnosis. |
Antigen Enzyme-Linked Immunosorbent Assay (ELISA) | Detection of B19V antigens in serum. | Useful for detecting B19V antigens; less commonly used than DNA-based methods. | Can support diagnosis, especially in conjunction with other tests. |
Hemagglutination | Detection of B19V through agglutination of red blood cells. | Rarely used in modern diagnostics. | Supplementary method. |
Direct Hybridization (Slot/Dot Blot) | Isolation of B19V DNA using labeled probes in clinical specimens. | Sensitive for detecting B19V DNA in acute and chronic infections; detection limit: ~105 genome copies/mL. | Effective for detecting B19V in acute cases and immunosuppressed patients. |
Polymerase Chain Reaction (PCR) | Amplification and detection of B19V DNA in serum and tissue samples. | Highly sensitive; detects low levels of viral DNA. | Primary method for diagnosing acute infection; essential for immunocompromised patients. |
Quantitative PCR (qPCR) | Measures viral load in clinical samples. | Quantifies viral DNA; useful for monitoring infection severity and treatment response. | Under investigation for blood product screening; important for managing severe cases. |
IgM Capture Assay | Detection of B19V-specific IgM antibodies. | Detects current or recent infection; IgM appears 3–10 days after onset and remains for 2–3 months. | Reliable for diagnosing recent infection in immunocompetent individuals. |
IgG Capture/Indirect Assay | Detection of B19V-specific IgG antibodies. | IgG appears 7–14 days after onset and persists for life. | Useful for determining past infection or immunity; not definitive for acute infection. |
NS1-Specific Antibody Detection | Detection of antibodies against the nonstructural protein NS1. | NS1-specific IgG appears late (>6 weeks); may indicate persistent infection or arthritis. | Can help exclude recent infections; controversial role in indicating persistent infection. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Ceccarelli, G.; Branda, F.; Ciccozzi, A.; Romano, C.; Sanna, D.; Casu, M.; Albanese, M.; Alessandri, F.; d’Ettorre, G.; Ciccozzi, M.; et al. Reassessing the Risk of Severe Parvovirus B19 Infection in the Immunocompetent Population: A Call for Vigilance in the Wake of Resurgence. Viruses 2024, 16, 1352. https://doi.org/10.3390/v16091352
Ceccarelli G, Branda F, Ciccozzi A, Romano C, Sanna D, Casu M, Albanese M, Alessandri F, d’Ettorre G, Ciccozzi M, et al. Reassessing the Risk of Severe Parvovirus B19 Infection in the Immunocompetent Population: A Call for Vigilance in the Wake of Resurgence. Viruses. 2024; 16(9):1352. https://doi.org/10.3390/v16091352
Chicago/Turabian StyleCeccarelli, Giancarlo, Francesco Branda, Alessandra Ciccozzi, Chiara Romano, Daria Sanna, Marco Casu, Mattia Albanese, Francesco Alessandri, Gabriella d’Ettorre, Massimo Ciccozzi, and et al. 2024. "Reassessing the Risk of Severe Parvovirus B19 Infection in the Immunocompetent Population: A Call for Vigilance in the Wake of Resurgence" Viruses 16, no. 9: 1352. https://doi.org/10.3390/v16091352